Medical and Science
What powers GenesisCare’s bold path in cancer research: Clinical Trials Day

What does it take to deliver research that truly changes lives? For Sonya McColl, National Research Manager of Oncology at GenesisCare, the Clinical Trials Day (20 May) theme of Powered by Purpose is more than a timely message, it’s a daily reality.
In this Health Industry Hub podcast, McColl explores how GenesisCare approaches clinical trials through a purpose-led lens, from the way research areas are selected to how funding is sourced from industry partnerships, academic collaborations, and other channels.
But McColl is also frank about the challenges. Diversity in trial participation and incorporating the patient voice more meaningfully into trial design is another critical frontier.
She reflects on recent prostate and breast cancer research milestones at GenesisCare and highlights their significant potential to improve patient outcomes, while also unpacking the economic and operational tensions of running local trials versus serving as a site within global studies. Despite Australia’s strong clinical trials reputation, several barriers continue to hold the sector back.
Looking ahead, McColl spotlights the emerging trends set to reshape oncology research that could dramatically shift the pace and precision of future clinical trials.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Biotechnology

CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
MoreNews & Trends - MedTech & Diagnostics

Australia joins Medtronic trial in fight against resistant hypertension
Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]
MoreNews & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]
MoreNews & Trends - Pharmaceuticals

Global pledge shifts visibility and action for patients with advanced breast cancer
Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]
More